Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Dioxins and related environmental contaminants increase TDP-43 levels.

Ash PEA, Stanford EA, Al Abdulatif A, Ramirez-Cardenas A, Ballance HI, Boudeau S, Jeh A, Murithi JM, Tripodis Y, Murphy GJ, Sherr DH, Wolozin B.

Mol Neurodegener. 2017 May 5;12(1):35. doi: 10.1186/s13024-017-0177-9.

2.

An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.

Novikov O, Wang Z, Stanford EA, Parks AJ, Ramirez-Cardenas A, Landesman E, Laklouk I, Sarita-Reyes C, Gusenleitner D, Li A, Monti S, Manteiga S, Lee K, Sherr DH.

Mol Pharmacol. 2016 Nov;90(5):674-688. Epub 2016 Aug 29.

3.

Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human Development.

Smith BW, Stanford EA, Sherr DH, Murphy GJ.

Stem Cells Int. 2016;2016:2574152. doi: 10.1155/2016/2574152. Epub 2016 Apr 11.

4.

Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis.

Stanford EA, Ramirez-Cardenas A, Wang Z, Novikov O, Alamoud K, Koutrakis P, Mizgerd JP, Genco CA, Kukuruzinska M, Monti S, Bais MV, Sherr DH.

Mol Cancer Res. 2016 Aug;14(8):696-706. doi: 10.1158/1541-7786.MCR-16-0069. Epub 2016 Apr 29.

5.

The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.

Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ, Sherr DH.

BMC Biol. 2016 Mar 16;14:20. doi: 10.1186/s12915-016-0240-y.

6.

In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.

Parks AJ, Pollastri MP, Hahn ME, Stanford EA, Novikov O, Franks DG, Haigh SE, Narasimhan S, Ashton TD, Hopper TG, Kozakov D, Beglov D, Vajda S, Schlezinger JJ, Sherr DH.

Mol Pharmacol. 2014 Nov;86(5):593-608. doi: 10.1124/mol.114.093369. Epub 2014 Aug 26.

7.

Hemodynamic performance of mitroflow aortic pericardial bioprosthesis - optimizing management for the small aortic annulus.

Jamieson WR, Forgie WR, Hayden RI, Langlois Y, Ling H, Stanford EA, Roberts KA, Dolman WB.

Thorac Cardiovasc Surg. 2010 Mar;58(2):69-75. doi: 10.1055/s-0029-1240626. Epub 2010 Mar 23.

PMID:
20333567
8.

Seven-year results with the St Jude Medical Silzone mechanical prosthesis.

Jamieson WR, Fradet GJ, Abel JG, Janusz MT, Lichtenstein SV, MacNab JS, Stanford EA, Chan F.

J Thorac Cardiovasc Surg. 2009 May;137(5):1109-15.e2. doi: 10.1016/j.jtcvs.2008.07.070.

9.

Effect of prosthesis-patient mismatch on long-term survival with mitral valve replacement: assessment to 15 years.

Jamieson WR, Germann E, Ye J, Chan F, Cheung A, MacNab JS, Fradet GJ, Stanford EA, Bryson LA, Lichtenstein SV.

Ann Thorac Surg. 2009 Apr;87(4):1135-41; discussion 1142. doi: 10.1016/j.athoracsur.2009.01.056.

PMID:
19324139
10.

Response biases in preschool children's ratings of pain in hypothetical situations.

von Baeyer CL, Forsyth SJ, Stanford EA, Watson M, Chambers CT.

Eur J Pain. 2009 Feb;13(2):209-13. doi: 10.1016/j.ejpain.2008.03.017. Epub 2008 May 13.

PMID:
18479952
11.

The frequency, trajectories and predictors of adolescent recurrent pain: a population-based approach.

Stanford EA, Chambers CT, Biesanz JC, Chen E.

Pain. 2008 Aug 15;138(1):11-21. Epub 2008 Feb 21.

PMID:
18093737
12.

The role of developmental factors in predicting young children's use of a self-report scale for pain.

Stanford EA, Chambers CT, Craig KD.

Pain. 2006 Jan;120(1-2):16-23. Epub 2005 Dec 13.

PMID:
16359800
13.

"Ow!": spontaneous verbal pain expression among young children during immunization.

Stanford EA, Chambers CT, Craig KD, McGrath PJ, Cassidy KL.

Clin J Pain. 2005 Nov-Dec;21(6):499-502.

PMID:
16215335
14.

A normative analysis of the development of pain-related vocabulary in children.

Stanford EA, Chambers CT, Craig KD.

Pain. 2005 Mar;114(1-2):278-84. Epub 2005 Jan 26.

PMID:
15733654
15.

Medtronic mosaic porcine bioprosthesis: investigational center experience to six years.

Jamieson WR, Fradet GJ, MacNab JS, Burr LH, Stanford EA, Janusz MT, Abel JG, Germann E, Cheung A.

J Heart Valve Dis. 2005 Jan;14(1):54-63.

PMID:
15700437
16.

Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices.

Dew MA, Kormos RL, Winowich S, Harris RC, Stanford EA, Carozza L, Griffith BP.

J Heart Lung Transplant. 2001 Nov;20(11):1199-212.

PMID:
11704480
17.

LVAD blood stream infection: therapeutic rationale for transplantation.

Poston RS, Sorce DN, Husain S, Stanford EA, Winowich S, Kusne S, Griffith BP, Kormos RL.

J Heart Lung Transplant. 2001 Feb;20(2):241-242. No abstract available.

PMID:
11250470
18.

Human factors issues in ventricular assist device recipients and their family caregivers.

Dew MA, Kormos RL, Winowich S, Stanford EA, Carozza L, Borovetz HS, Griffith BP.

ASAIO J. 2000 May-Jun;46(3):367-73.

PMID:
10826754
19.

Freeze-drying today and tomorrow.

Leary JH, Stanford EA.

Dev Biol Stand. 1976 Oct;36:221-9.

PMID:
1030422

Supplemental Content

Loading ...
Support Center